Clinical study "common" name (formal title)	Number of enrollees (per protocol [PP]/intent-to-treat [ITT])	Funding source (pharmaceutical company/National Institutes of Health [NIH])	Year completed	Primary publication	Full study treatment protocol
Three-Year Visual Outcomes of Intravitreal Ranibizumab With or Without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy	45 patients	N/A	2012	Sakai T, Okano K, Kohno H, Tsuneoka H. Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy. Acta Ophthalmol. 2016;94(8):e765-e771. https://onlinelibrary.wiley.com/doi/10.1111/aos.13130	N/A